PLYX
Polaryx Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.88
+1.08%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-62.6%
Return on equity
-58.0%
Return on assets
-47.7%
Return on invested capital
0.00x
Asset turnover
-$5.8M
Cash from operations
$0.23
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026